These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38023116)

  • 21. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.
    Levin FR; Bisaga A; Sullivan MA; Williams AR; Cates-Wessel K
    Am J Addict; 2016 Dec; 25(8):603-609. PubMed ID: 28051841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of Didactic Training on Barriers and Biases to Treatment of Opioid Use Disorder: Meeting the Ongoing Needs of Patients with Opioid Use Disorder in the Emergency Department during the COVID-19 Pandemic.
    Johnson E; Bolshakova M; Vosooghi A; Lam CN; Trotzky-Sirr R; Bluthenthal R; Schneberk T
    Healthcare (Basel); 2022 Nov; 10(12):. PubMed ID: 36553917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
    Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
    Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of hepatitis C screening within a pharmacist-managed medication-assisted therapy opioid use disorder protocol program.
    Llayton CK; Harlow CP; Burris JN; Rhodes J
    J Am Pharm Assoc (2003); 2020; 60(6):e307-e311. PubMed ID: 32527703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring first responders' perceptions of medication for addiction treatment: Does stigma influence attitudes?
    Kruis NE; McLean K; Perry P
    J Subst Abuse Treat; 2021 Dec; 131():108485. PubMed ID: 34098289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia.
    Saloner B; Landis R; Stein BD; Barry CL
    Health Aff (Millwood); 2019 Apr; 38(4):633-642. PubMed ID: 30933592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming Barriers: Individual Experiences Obtaining Medication-Assisted Treatment for Opioid Use Disorder.
    Scorsone KL; Haozous EA; Hayes L; Cox KJ
    Qual Health Res; 2020 Nov; 30(13):2103-2117. PubMed ID: 32691670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does a Rural Community-Based Intervention Improve Knowledge and Attitudes of Opioid Use Disorder and Medication-Assisted Treatment? A Report From the IT MATTTRs Study.
    Curcija K; Zittleman L; Fisher M; Nease DE; Dickinson LM; de la Cerda D; Sutter C; Ancona J; Rank J; Westfall JM
    J Rural Health; 2022 Jan; 38(1):120-128. PubMed ID: 33244841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.
    Bunting AM; Oser CB; Staton M; Eddens KS; Knudsen H
    Addict Sci Clin Pract; 2018 Dec; 13(1):23. PubMed ID: 30509314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds.
    Kitsantas P; Aljoudi SM; Baker KM; Peppard L; Oh KM
    J Subst Use Addict Treat; 2023 May; 148():208960. PubMed ID: 37102193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing Peer Recovery Support Services to Address the Central Appalachian Opioid Epidemic: The West Virginia Peers Enhancing Education, Recovery, and Survival (WV PEERS) Pilot Program.
    Davis SM; Stover AN; Linn H; Dower J; McCawley D; Winstanley EL; Feinberg J
    J Appalach Health; 2021; 3(3):36-50. PubMed ID: 35770037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
    Shea CM; Gertner AK; Green SL
    Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans.
    Kirby T; Connell R; Linneman T
    Am J Health Syst Pharm; 2021 Feb; 78(4):301-309. PubMed ID: 33289022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiences with Medications for Addiction Treatment Among Emergency Department Patients with Opioid Use Disorder.
    Goldfine CE; Chapman BP; Taylor MM; Bradley ES; Carreiro SP; Rosen RK; Babu KM; Lai JT
    West J Emerg Med; 2023 Feb; 24(2):236-242. PubMed ID: 36976598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program.
    Martin RA; Gresko SA; Brinkley-Rubinstein L; Stein LAR; Clarke JG
    Prev Med; 2019 Nov; 128():105766. PubMed ID: 31279770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
    Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
    Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.